Deborah A. Evrard

739 total citations
15 papers, 567 citations indexed

About

Deborah A. Evrard is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Deborah A. Evrard has authored 15 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 10 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Deborah A. Evrard's work include Synthesis and Biological Evaluation (8 papers), Receptor Mechanisms and Signaling (4 papers) and Chemical Synthesis and Analysis (3 papers). Deborah A. Evrard is often cited by papers focused on Synthesis and Biological Evaluation (8 papers), Receptor Mechanisms and Signaling (4 papers) and Chemical Synthesis and Analysis (3 papers). Deborah A. Evrard collaborates with scholars based in United States, China and Canada. Deborah A. Evrard's co-authors include David A. Evans, Christopher J. Dinsmore, Keith M. DeVries, Pawel Fludzinski, Marlene L. Cohen, Andrew M. Ratz, James C. Barrow, Jeffrey S. Nissen, James E. Audia and Deborah L. Smith and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Deborah A. Evrard

15 papers receiving 539 citations

Peers

Deborah A. Evrard

PHARM

CMN

PHARM

Douglas C. Beshore United States

Kevin G. Liu United States

Hana Kopecka United States

Suman Rakhit United States

Richard T. Beresis United States

Peter R. Guzzo United States

Jae‐Kyu Jung United States

Alan Stobie United Kingdom

John R. Carson United States

Ignacio Carrera Uruguay

Douglas C. Beshore United States

Deborah A. Evrard

451 ×1.1

391 ×1.4

114 ×0.9

PHARM

90 ×1.0

CMN

24 ×0.6

PHARM

Citations per year, relative to Deborah A. Evrard Deborah A. Evrard (= 1×) peers Douglas C. Beshore

Countries citing papers authored by Deborah A. Evrard

Since Specialization

Citations

This map shows the geographic impact of Deborah A. Evrard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Evrard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Evrard more than expected).

Fields of papers citing papers by Deborah A. Evrard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Evrard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Evrard. The network helps show where Deborah A. Evrard may publish in the future.

Co-authorship network of co-authors of Deborah A. Evrard

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah A. Evrard. A scholar is included among the top collaborators of Deborah A. Evrard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah A. Evrard. Deborah A. Evrard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Venkatesan, Aranapakam M., Osvaldo dos Santos, John W. Ellingboe, et al.. (2010). Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity. Bioorganic & Medicinal Chemistry Letters. 20(3). 824–827. 26 indexed citations

Shen, Zhongqi, Nicole T. Hatzenbuhler, Deborah A. Evrard, et al.. (2009). Synthesis and structure–activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT1A receptor and the serotonin transporter. Bioorganic & Medicinal Chemistry Letters. 20(1). 222–227. 14 indexed citations

Zhou, Dahui, Ping Zhou, Deborah A. Evrard, et al.. (2008). Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives. Bioorganic & Medicinal Chemistry. 16(14). 6707–6723. 21 indexed citations

Nikitenko, Antonia A., Asaf Alimardanov, J. Schmid, et al.. (2008). First Scale-Up Synthesis of WAY-262398, a Novel, Dual-Acting SSRI/5HT1a Antagonist. Organic Process Research & Development. 13(1). 91–97. 6 indexed citations

Zhou, Dahui, Nicole T. Hatzenbuhler, Jonathan Groß, et al.. (2007). Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor. Bioorganic & Medicinal Chemistry Letters. 17(11). 3117–3121. 8 indexed citations

Nikitenko, Antonia A., Deborah A. Evrard, Annmarie L. Sabb, et al.. (2007). First Scale-Up: Problems and Resolutions on the Synthesis of WAY-253752, a Novel, Dual-Acting SSRI/5HT_1A Antagonist. Organic Process Research & Development. 12(1). 76–80. 22 indexed citations

Hatzenbuhler, Nicole T., Deborah A. Evrard, Boyd L. Harrison, et al.. (2006). Synthesis and Biological Evaluation of Novel Compounds within a Class of 3-Aminochroman Derivatives with Dual 5-HT_1AReceptor and Serotonin Transporter Affinity. Journal of Medicinal Chemistry. 49(15). 4785–4789. 24 indexed citations

Evrard, Deborah A., Ping Zhou, Dahui Zhou, et al.. (2005). Studies towards the next generation of antidepressants. Part 4: Derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor. Bioorganic & Medicinal Chemistry Letters. 15(4). 911–914. 22 indexed citations

Meagher, Kristin L., Richard E. Mewshaw, Deborah A. Evrard, et al.. (2001). Studies towards the next generation of antidepressants. Part 1: indolylcyclohexylamines as potent serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(14). 1885–1888. 28 indexed citations

10.

Evans, David A., Christopher J. Dinsmore, Andrew M. Ratz, Deborah A. Evrard, & James C. Barrow. (1997). Synthesis and Conformational Properties of the M(4-6)(5-7) Bicyclic Tetrapeptide Common to the Vancomycin Antibiotics. Journal of the American Chemical Society. 119(14). 3417–3418. 57 indexed citations

11.

Evans, David A., James C. Barrow, Paul S. Watson, et al.. (1997). Approaches to the Synthesis of the Vancomycin Antibiotics. Synthesis of Orienticin C (Bis-dechlorovancomycin) Aglycon. Journal of the American Chemical Society. 119(14). 3419–3420. 65 indexed citations

12.

Audia, James E., et al.. (1996). “Pictet-Spengler-like” Synthesis of Tetrahydro-β-carbolines under Hydrolytic Conditions. Direct Use of Azalactones as Phenylacetaldehyde Equivalents. The Journal of Organic Chemistry. 61(22). 7937–7939. 14 indexed citations

13.

Audia, James E., Deborah A. Evrard, Jeffrey S. Nissen, et al.. (1996). Potent, Selective Tetrahydro-β-carboline Antagonists of the Serotonin 2B (5HT_2B) Contractile Receptor in the Rat Stomach Fundus. Journal of Medicinal Chemistry. 39(14). 2773–2780. 104 indexed citations

14.

Evans, David A., Christopher J. Dinsmore, Deborah A. Evrard, & Keith M. DeVries. (1993). Oxidative coupling of arylglycine-containing peptides. A biomimetic approach to the synthesis of the macrocyclic actinoidinic-containing vancomycin subunit. Journal of the American Chemical Society. 115(14). 6426–6427. 91 indexed citations

15.

Fludzinski, Pawel, Deborah A. Evrard, William B. Lacefield, et al.. (1987). Indazoles as indole bioisosteres: synthesis and evaluation of the tropanyl ester and amide of indazole-3-carboxylate as antagonists at the serotonin 5HT3 receptor. Journal of Medicinal Chemistry. 30(9). 1535–1537. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact